Shuimu BioSciences ^Company

Shuimu harnesses the power of cryo-EM and Artificial Intelligence to help pharma and biotech companies discover and develop novel therapeutics faster and better, breaks new ground to develop precision medicines for the most challenging diseases on our planet.
With eight 300kv Cryo-EM’s in house, proprietory GraFuture technologies, AI driven data processing and modeling platforms, Shuimu is your best partner with one-stop solutions in structure based drug and therapeutic innovation, from sequence to structure.